Heron Therapeutics Revenue, Growth & Competitor Profile

DBA A.P. PHARMA, INC.

Company Profile & Annual Report for Heron Therapeutics

Access the complete profile.

Heron Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	4242 Campus Point Ct Ste 200 San Diego, CA 92121

Note: Revenues for privately held companies are statistical evaluations.


Heron Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Heron Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Heron Therapeutics is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Heron Therapeutics Annual Revenue and Growth Rate

Heron Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Heron Therapeutics's revenues are gauged from an analysis of company filings.

Heron Therapeutics's Income Statement (based on Industry Averages)

Heron Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Heron Therapeutics is developing and marketing. Heron Therapeutics doesn't have any recent trademark applications, indicating Heron Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
APONVI Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy	09/21/2021
APONVIE Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy	09/21/2021
HERON Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the treatment of pain, gastrointestinal conditions, cancer, inflammatory diseases and genetic diseases; pharmaceutical preparations and substances, namely, anesthetics for surgical purposes; anesthetics for surgical use; inhalant anesthetics; local anesthetics; topical anesthetics; general anesthetics; anti-inflammatory preparations; anti-inflammatory ointments; analgesic preparations; preparations for the relief of pain; anesthetics for peri-operative and post-operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain	08/31/2021

See all trademarks and details in the Full Report.

Market Share of Heron Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Heron Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Heron Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
DEXCOM	San Diego, CA	100
TANDEM DIABETES CARE	San Diego, CA	54
NUVASIVE	San Diego, CA	42
AGENA BIOSCIENCE	San Diego, CA	3
HERON THERAPEUTICS	San Diego, CA	2
INNOVIVE	San Diego, CA	1

Future Competition: Heron Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Heron Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)